Epoprostenol

Epoprostenol

SCHEMBL3165288

CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C\CCCC(=O)O)O[C@H]2C[C@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PTGIR

The experimentally established mechanism targets of Epoprostenol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGIR known ✓ P43119 6/20 0.56
▸ ALDH1A1 P00352 5/20 1.00
▸ MEN1 O00255 2/20 0.71
▸ KMT2A Q03164 2/20 0.71
▸ PPARD Q03181 2/20 0.71
▸ PPARA Q07869 2/20 0.71
▸ PPARG P37231 1/20 0.71
▸ PTGER4 P35408 4/20 0.56
▸ TBXA2R P21731 3/20 0.56
▸ PTGER1 P34995 2/20 0.56
▸ PTGFR P43088 2/20 0.56
▸ PTGER3 P43115 2/20 0.56
▸ LMNA P02545 2/20 0.56
▸ PTGDR Q13258 1/20 0.56
▸ SLCO2A1 Q92959 1/20 0.56
▸ PTGER2 P43116 3/20 0.56
▸ TSHR P16473 3/20 0.56
▸ HPGD P15428 2/20 0.56
▸ MAPK1 P28482 2/20 0.56
▸ NR1I2 O75469 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Epoprostenol SCHEMBL13649344 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2APPARDPPARA
Epoprostenol SCHEMBL8041 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2APPARDPPARA
Epoprostenol SCHEMBL22607961 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2APPARDPPARA
Epoprostenol SCHEMBL24340812 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2APPARDPPARA
Epoprostenol SCHEMBL551617 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2APPARDPPARA
Epoprostenol SCHEMBL24033081 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2APPARDPPARA
Epoprostenol SCHEMBL6227413 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2APPARDPPARA
Epoprostenol SCHEMBL24612535 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2APPARDPPARA
Epoprostenol SCHEMBL21283002 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2APPARDPPARA
Epoprostenol SCHEMBL8042 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2APPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7645601-B2 Methods and means for modulating PGE synthase activity KAROLINSKA INNOVATIONS AB (SE) 2010-01-12 — — US disclosed
US-7192733-B2 Methods and means for modulating PGE synthase activity KAROLINSKA INNOVATIONS AB (SE) 2007-03-20 — — US disclosed
US-7067296-B2 Methods and means for modulating PGE synthase activity KAROLINSKA INNOVATIONS AB (SE) 2006-06-27 — — US disclosed
EP-1129188-B1 PGE SYNTHASE AND METHODS AND MEANS FOR MODULATING ITS ACTIVITY KAROLINSKA INNOVATIONS AB (SE) 2005-09-21 — — EP disclosed
US-20050118696-A1 Methods and means for modulating PGE synthase activity JAKOBSSON PER-JOHAN (SE) 2005-06-02 — — US disclosed
US-20030064493-A1 Methods and means for modulating PGE synthase activity JAKOBSSON PER-JOHAN (SE) 2003-04-03 — — US disclosed
US-6395502-B1 DETECTING MODULATORS OF PROSTAGLANDIN PEROXIDASE; OBTAIN SAMPLE, INCUBATE WITH PREFERENTIAL POLYPEPTIDE, MONITOR PRODUCTS KAROLINSKA INNOVATIONS AB (SE) 2002-05-28 — — US disclosed
Send feedback